Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Med Food ; 23(2): 139-146, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31486703

RESUMEN

Tendinopathy, a common disorder in man and horses, is characterized by pain, dysfunction, and tendon degeneration. Inflammation plays a key role in the pathogenesis of tendinopathy. Tendon cells produce proinflammatory molecules that induce pain and tissue deterioration. Currently used nonsteroidal anti-inflammatory drugs are palliative but have been associated with adverse side effects prompting the search for safe, alternative compounds. This study determined whether tendon-derived cells' expression of proinflammatory cyclooxygenase (COX)-2 and production of prostaglandin E2 (PGE2) could be attenuated by the combination of avocado/soybean unsaponifiables (ASU), glucosamine (GLU), and chondroitin sulfate (CS). ASU, GLU, and CS have been used in the management of osteoarthritis-associated joint inflammation. Tenocytes in monolayer and microcarrier spinner cultures were incubated with media alone, or with the combination of ASU (8.3 µg/mL), GLU (11 µg/mL), and CS (20 µg/mL). Cultures were next incubated with media alone, or stimulated with interleukin-1ß (IL-1ß; 10 ng/mL) for 1 h to measure COX-2 gene expression, or for 24 h to measure PGE2 production, respectively. Tenocyte phenotype was analyzed by phase-contrast microscopy, immunocytochemistry, and Western blotting. Tendon-derived cells proliferated and produced extracellular matrix component type I collagen in monolayer and microcarrier spinner cultures. IL-1ß-induced COX-2 gene expression and PGE2 production were significantly reduced by the combination of (ASU+GLU+CS). The suppression of IL-1ß-induced inflammatory response suggests that (ASU+GLU+CS) may help attenuate deleterious inflammation in tendons.


Asunto(s)
Sulfatos de Condroitina/farmacología , Dinoprostona/metabolismo , Glucosamina/farmacología , Glycine max/química , Persea/química , Tenocitos/efectos de los fármacos , Animales , Antiinflamatorios/farmacología , Células Cultivadas , Ciclooxigenasa 2/metabolismo , Caballos , Interleucina-1beta/farmacología , Fitoquímicos/farmacología , Preparaciones de Plantas/uso terapéutico , Tendinopatía
2.
Cartilage ; 9(3): 304-312, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29156944

RESUMEN

Objective Pro-inflammatory mediators such as prostaglandin E-2 (PGE2) play major roles in the pathogenesis of osteoarthritis (OA). Although current pharmacologic treatments reduce inflammation, their prolonged use is associated with deleterious side effects prompting the search for safer and effective alternative strategies. The present study evaluated whether chondrocyte production of PGE2 can be suppressed by the combination of avocado/soybean unsaponifiables (ASU) and α-lipoic acid (LA). Design Chondrocytes from articular cartilage of equine joints were incubated for 24 hours with: (1) control media, (2) ASU, (3) LA, or (4) ASU + LA combination. Cells were activated with lipopolysaccharide (LPS), interleukin 1ß (IL-1ß) or hydrogen peroxide (H2O2) for 24 hours and supernatants were immunoassayed for PGE2. Nuclear factor-kappa B (NF-κB) analyses were performed by immunocytochemistry and Western blot following 1 hour of activation with IL-1ß. Results LPS, IL-1ß, or H2O2 significantly increased PGE2 production. ASU or LA alone suppressed PGE2 production in LPS and IL-1ß activated cells. Only LA alone at 2.5 µg/mL was inhibitory in H2O2-activated chondrocytes. ASU + LA inhibited more than either agent alone in all activated cells. ASU + LA also inhibited the IL-1ß induced nuclear translocation of NF-κB. Conclusions The present study provides evidence that chondrocyte PGE2 production can be inhibited by the combination of ASU + LA more effectively than either ASU or LA alone. Inhibition of PGE2 production is associated with the suppression of NF-κB translocation. The potent inhibitory effect of ASU + LA on PGE2 production could offer a potential advantage for a combination anti-inflammatory/antioxidant approach in the management of OA.


Asunto(s)
Células Cultivadas/efectos de los fármacos , Condrocitos/citología , Osteoartritis/metabolismo , Persea/efectos adversos , Aceite de Soja/farmacología , Ácido Tióctico/farmacología , Animales , Antiinflamatorios/efectos adversos , Antiinflamatorios/metabolismo , Antiinflamatorios/farmacología , Cartílago Articular/citología , Cartílago Articular/efectos de los fármacos , Cartílago Articular/metabolismo , Condrocitos/efectos de los fármacos , Condrocitos/metabolismo , Terapia Combinada/métodos , Dinoprostona/biosíntesis , Dinoprostona/metabolismo , Modelos Animales de Enfermedad , Caballos , Peróxido de Hidrógeno/metabolismo , Peróxido de Hidrógeno/farmacología , Inflamación/tratamiento farmacológico , Interleucina-1beta/metabolismo , Interleucina-1beta/farmacología , Lipopolisacáridos/metabolismo , Lipopolisacáridos/farmacología , FN-kappa B/metabolismo , FN-kappa B/farmacología , Osteoartritis/tratamiento farmacológico , Osteoartritis/fisiopatología , Persea/metabolismo , Extractos Vegetales/farmacología , Aceite de Soja/efectos adversos , Aceite de Soja/metabolismo , Ácido Tióctico/efectos adversos , Ácido Tióctico/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA